Research At Alivation
Dr. Walt Duffy, Founder and Medical Director of Alivation Research, has been the Principal Investigator on over 150 clinical trials since 2005. Alivation could not have done it without the participation of the general public. Take a look at our current studies to see if you are eligible to participate.
ABOUT US
Alivation Research takes part in research studies that help further science and medicine, and we are constantly looking for qualified candidates to help gather this data. Our goal is to measure results, determine the safety and tolerability of treatment options, and make it possible for our patients to access the newest treatments when traditional treatments may not be working. Participants are often compensated for their time and travel and receive their study medication and devices at no cost.
What do you get out of it?
Compensation from our research sponsors.
Access to new, investigational, treatment options.
A feeling that you have participated in something meaningful.
A chance to contribute to science and your communities.
What Research Studies Do We Currently Offer?
Alivation Research offers both adult and pediatric studies. Each study has their own distinct requirements so be sure to read the indication carefully. If you're interested in learning more, complete the form below and we will be in contact with you soon.
Adult Studies
--- Indication: Treatment Resistant Depression Investigational Product: Comp360 Age: 19 or older Compensation: $50 to $100 per visit, $500 on initial treatment day
--- Indication: Generalized Anxiety Disorder Investigational Product: MM120 Age: 19 to 74 years old Compensation: $60 per completed visit and $300 for completed dosing visit (Up to 5 dosing visits can be scheduled if eligibility is continued to be met.)
--- Indication: Early Alzheimer's Disease Investigational Product: AR1001 Age: 55 to 80 years old Compensation: $975 payable to both participant and caregiver (separately) if all study visits are completed. Additional compensation available if participant completes extension visits.
--- Indication: ADHD Investigational Product: Solriamfetol Age: 19 or older Compensation: $950 (max)
--- Indication: Major Depressive Disorder Investigational Product: SP-624 Age: 19 or older Compensation: $800 (max)
Pediatric Studies
--- Indication: Autism Spectrum Disorder Investigational Product: Lumateperone Age: 5 to 12 Compensation: $2,600 (max)
--- Indication: ADHD Investigational Product: Centanafadine Age: 4 to 5 Compensation: $53 per visit
--- Indication: Major Depressive Episodes associated with Bipolar Depression Investigational Product: Lumateperone Ages: 10 to 17 Compensation: $1,800 (max)
--- Indication: Pediatric Bipolar 1 Disorder Investigational Product: Olanzapine/Samidorphan Ages: 10 to 17 Compensation: $2,100 (max)
--- Indication: ADHD Investigational Product: Methylphenidate Hydrochloride Ages: 4 to 5 Compensation: TBD
Want to Join a Study?
If you think that you fit any of the requirements for our research studies fill out this form below, which will then be sent to us for review. If you qualify for the research study, we will have a member of our team get back to you on the next steps. To expedite the process, please print the ROI Form and have your healthcare professional complete it.
For Sponsors/CRO's
If you are looking to work with Alivation Research. Please fill out and submit this form.
Our Research Team
Address
8550 Cuthills Circle,
Lincoln, NE 68526
Phone
402-817-2243